Company news
Bubs Australia Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Completion of $14M Placement and Launches SPP
November 23, 2023
Capital Raising Investor Presentation
November 23, 2023
Trading Halt
November 21, 2023
Bubs Q1 FY24 Quarterly Activity and Cashflow Statement
October 23, 2023
Bubs Announces US-Based Infant Formula Clinical Trial
September 6, 2023
Bubs FY23 Results
August 31, 2023
Bubs Appendix 4E - Preliminary Final Report
August 31, 2023
Bubs CEO Appointment
August 28, 2023
Bubs Q4 FY23 Quarterly Activity and Cashflow Statement
July 30, 2023
Strategic Review - Presentation
July 5, 2023
Strategic Review
July 5, 2023
Alpha Group Legal Dispute
July 3, 2023
Bubs China Update
June 30, 2023
USA Update
June 20, 2023
Trading Update
June 2, 2023
Bubs Australia Limited - CEO Termination
May 10, 2023
FY23 Q3 - Activity Report and Appendix 4C Cashflow Statement
April 27, 2023
Half Year Results and Appendix 4D
February 27, 2023
Non - Cash Impairment
February 27, 2023
Pause in Trading
February 26, 2023
FY23 Q2 - Activity Report and Appendix 4C Cashflow Statement
January 30, 2023
FY23 Q1 - Activity Report and Appendix 4C Cashflow Statement
October 30, 2022
Bubs Lodges Letter of Intent with FDA
October 2, 2022
SAMR Registration Pathway Bubs China Label Infant Formula
September 28, 2022
Appendix 4E
August 29, 2022
Completion of Retail Entitlement Offer - Amended
July 29, 2022
Completion of Retail Entitlement Offer
July 28, 2022
FY22 Q4 - Activity Report and Appendix 4C Cashflow Statement
July 19, 2022
Appendix 3B - Amended
July 14, 2022
Retail Offer Booklet and Letter to Ineligible Shareholders
July 13, 2022
FDA Framework and New Operation Fly Formula
July 6, 2022
Completion of Institutional Offer
July 6, 2022
Investor Presentation
July 5, 2022
Bubs Announces Equity Raising
July 5, 2022
Appendix 3B
July 4, 2022
Bubs Australia Announces Equity Raising
July 4, 2022
New USA Retailers, WIC and Tariff Concession
July 3, 2022
Bubs Enters USA Supplier Agreement with Target
June 28, 2022
President Biden Announces New Operation Fly Formula Mission
June 22, 2022
Upgrade to FY22 Market Guidance
June 16, 2022
BUBS Enters into Supply Agreement with Walmart USA
June 15, 2022
Major USA Supply Agreements with Kroger and Albertsons
June 9, 2022
USA Operation Fly Formula - White House Roundtable
June 1, 2022
USA FDA discretion to import Bubs Infant Formula
May 29, 2022
FY22 Q3 - Activity Report and Appendix 4C Cashflow Statement
April 25, 2022
Bubs launches A2 beta-casein protein infant formula
March 21, 2022
Bubs Strategic Alliance with Lead Daigou Distributor
March 2, 2022
Appendix 4D - Half Year Results
February 22, 2022
FY22 Q2 - Activity Report and Appendix 4C Cashflow Statement
January 30, 2022
AGM Presentation
November 29, 2021
Calls
Decks
The 5 newest of 51 decks. Every deck is listed under its year.
- Corporate Update (September 2026)
Corporate update · 14 slides · Sep 10, 2026
- FY2026 Earnings Presentation
Earnings · 21 slides · Aug 27, 2026
- Investor Day (March 2026)
Investor day · 51 slides · Mar 26, 2026
- Investor Day (March 2026)
Investor day · 50 slides · Mar 26, 2026
- 1H FY26 Earnings Presentation
Earnings · 24 slides · Feb 27, 2026